Programme

Concizumab Phase 3 Trial (explorer7) Alhemo® in Haemophilia A and B Patients with Inhibitors 

Bleeding Management of Inhibitor Patients before and in the Era of Non-Factor Prophylaxis 

Role of Extended Recombinant Factors – Esperoct® and Refixia® 

Concizumab Phase 3 Trial (explorer8) Alhemo® in Haemophilia A and B without Inhibitors 

Severe Postpartum Haemorrhage: Emerging Management Options 

Early Diagnosis of Postpartum Acquired Haemophilia

Haemostasis Strategies in Postpartum Acquired Haemophilia